Lipid Sciences, Inc. Licenses Unique Assay Technology From The Children's Hospital of Philadelphia

PLEASANTON, CA -- (MARKET WIRE) -- April 16, 2007 -- Lipid Sciences, Inc. (NASDAQ: LIPD) announced that the Company has entered into an agreement to license a unique in vitro assay technology from The Children's Hospital of Philadelphia. The agreement is for a period of one year and can be renewed for one year increments thereafter. The License Agreement covers intellectual property described in the patent, "Cell Culture System for Determining the Cholesterol Efflux Potential for Serum." The inventor on the patent is George H. Rothblat, Ph.D., Department of Pediatrics, The Joseph Stokes, Jr., Research Institute, The Children's Hospital of Philadelphia.